Table S7 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors по Joseph Toker (15399882)

Другие авторы:

Table S3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors по Joseph Toker (15399882)

Другие авторы:

Table S2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors по Joseph Toker (15399882)

Другие авторы:

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors по Joseph Toker (15399882)

Другие авторы:

Table S8 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors по Joseph Toker (15399882)

Другие авторы:

Table S5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors по Joseph Toker (15399882)

Другие авторы:

Table S4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors по Joseph Toker (15399882)

Другие авторы:

Table S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Figure S8 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Figure S5 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Figure S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Figure S3 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Table S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Figure S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Figure S7 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Figure S1 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Figure S6 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4⁺ T-cell Responses in Glioblastoma по Jian Wang (15048011)

Другие авторы:

Supplementary Tables from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities по Elisa ten Hacken (15136187)

Другие авторы:

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer по Francisco Hermida-Prado (14958909)

Другие авторы: